RANDY H. THURMAN

Insider Reports History

Location
Chicago, IL
Signature
/s/Lawrence A. Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by RANDY H. THURMAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Director Stock Option (Right to Buy) 286,734 01 Oct 2025 Direct
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 84,670 29 Sep 2022 Direct
TFF Pharmaceuticals, Inc. Director Common Stock 0 $0.3916 29 Sep 2022 Direct

Insider Reports Filed by RANDY H. THURMAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 01 Oct 2025 1 $0 4 Director 03 Oct 2025, 19:00
OTLK Outlook Therapeutics, Inc. 01 Oct 2024 2 $0 4 Director 03 Oct 2024, 20:30
OTLK Outlook Therapeutics, Inc. 07 Mar 2024 1 $0 4 Director 08 Mar 2024, 16:04
OTLK Outlook Therapeutics, Inc. 29 Mar 2023 1 $0 4 Director 31 Mar 2023, 17:44
/report/000121390022060782-thurman-randy-h-2022-09-29 TFF Pharmaceuticals, Inc. 29 Sep 2022 3 -$72,056 4 Director 30 Sep 2022, 17:20
OTLK Outlook Therapeutics, Inc. 23 Mar 2022 1 $0 4 Director 24 Mar 2022, 17:36
/report/000121390021027899-thurman-randy-h-2021-05-18 TFF Pharmaceuticals, Inc. 18 May 2021 1 +$9,870 4 Director 19 May 2021, 16:05